|
|
||||||||
Published online before print May 22, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
@
*Department of Tumor Progression and Tumor Defense, German Cancer Research Center, Heidelberg, Germany; and
Department of Applied Genetics, University of Karlsruhe, Germany
@ To whom correspondence should be addressed. E-mail: m.zoeller{at}dkfz.de.
| Abstract |
|---|
Blockade of CD44v7 was described to cure trinitrobenzene sulfonic acid-induced colitis, a disease not developed by mice with targeted deletion of the CD44v7 exon. There was evidence for a reduction in activation-induced cell death on lamina propria lymphocytes of control as compared with CD44v7-deficient mice. To elucidate the mechanism underlying the relative apoptosis resistance of CD44v7-competent as compared with CD44v7-deficient lymphocytes, T cell activation and induction of apoptosis were analyzed on mesenteric lymph node cells and Peyer's patch lymphocytes of CD44v7-deficient and CD44v4-v7-transgenic mice, which overexpress rat CD44v4-v7 on T lymphocytes. CD44v7 deficiency was characterized by an increase in the percentage of apoptotic cells after stimulation, increased numbers of CD95L- and CD152-positive cells, low levels of the antiapoptotic proteins Bcl-2 and Bcl-Xl, and decreased phosphorylation of the proapoptotic protein BAD. Also, lymphocytes from CD44v4-v7-transgenic mice displayed reduced levels of CD95L, low numbers of apoptotic cells, and constitutively elevated levels of Bcl-Xl. When stimulating lymphocytes by CD3 cross-linking, CD44v7 was not recruited toward the immunological synapse and preferentially associated with the cytoskeletal-linker protein ezrin. Thus, as opposed to the CD44 standard isoform, CD44v7 does not function as an accessory molecule; instead, it supports survival of activated T cells by interfering with activation-induced cell death.
Key Words: rodent autoimmunity adhesion molecules apoptosis signal transduction
This article has been cited by other articles:
![]() |
M. Ori, M. Nardini, P. Casini, R. Perris, and I. Nardi XHas2 activity is required during somitogenesis and precursor cell migration in Xenopus development Development, February 15, 2006; 133(4): 631 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Hauptschein, K. E. Sloan, C. Torella, R. Moezzifard, M. Giel-Moloney, C. Zehetmeier, C. Unger, L. L. Ilag, and D. G. Jay Functional Proteomic Screen Identifies a Modulating Role for CD44 in Death Receptor-Mediated Apoptosis Cancer Res., March 1, 2005; 65(5): 1887 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Krettek, G. K. Sukhova, U. Schonbeck, and P. Libby Enhanced Expression of CD44 Variants in Human Atheroma and Abdominal Aortic Aneurysm: Possible Role for a Feedback Loop in Endothelial Cells Am. J. Pathol., November 1, 2004; 165(5): 1571 - 1581. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |